Evidence map›Paper›PMID 36255643›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2023

Expression and Crystallization of HDAC6 Tandem Catalytic Domains.

Gerasimos Langousis, Jacint Sanchez, Georg Kempf, Patrick Matthias

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 70% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Gerasimos LangousisFriedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Jacint SanchezFriedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Georg KempfFriedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Patrick MatthiasFriedrich Miescher Institute for Biomedical Research, Basel, Switzerland. patrick.matthias@fmi.ch.
Friedrich Miescher Institute · CHUniversity of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Histone deacetylase 6 (HDAC6) is an atypical lysine deacetylase with tandem catalytic domains and an ubiquitin-binding zinc finger domain. HDAC6 is involved in various biological processes, such as cell motility or stress responses, and has been implicated in pathologies ranging from cancer to neurodegeneration. Due to this broad range of functions, there has been considerable interest in developing HDAC6-specific small molecule inhibitors, several of which are already available. The crystal structure of the tandem catalytic domains of zebrafish HDAC6 has revealed an arrangement with twofold symmetry and extensive surface interaction between the catalytic domains. Further dissection of the biochemical properties of HDAC6 and the development of novel inhibitors will benefit from being able to routinely express high-quality protein. We present here our optimized protocol for expression and crystallization of the zebrafish tandem catalytic domains.

Indexed as

LysineZebrafishAcetylationAnimalsCatalytic DomainCrystallizationHistone Deacetylase 6Histone Deacetylase InhibitorsUbiquitinsHistone Deacetylase 6Histone Deacetylase InhibitorsLysineUbiquitinsCatalytic domainsCrystallographyHDAC6InhibitorsProtein acetylation

Identifiers

PMID36255643
OpenAlexW4306731530

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.